Filgrastim Injection is used to decrease the chance of infection in people who have non myeloid cancer (cancer that does not involve the bone marrow) and are receiving chemotherapy medications that may decrease the number of neutrophils (a type of blood cell needed to fight infection). Filgrastim injection is also used to help increase the number of white blood cells, and decrease the length of time with fever in people with acute myeloid leukemia (AML; a type of cancer of the white blood cells) who are receiving treatment with chemotherapy medications. Filgrastim injection is also used in people who are undergoing bone marrow transplants, in people who have severe chronic neutropenia (condition in which there are a low number of neutrophils in the blood), and to prepare the blood for leukapheresis (a treatment in which certain blood cells are removed from the body. Filgrastim injection is also used to increase the chance of survival in people who have been exposed to harmful amounts of radiation, which can cause severe and life-threatening damage to the bone marrow. Filgrastim is in a class of medications called colony-stimulating factors. It works by helping the body make more neutrophils.
The global Filgrastim Injection market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2029, growing at a CAGR of % during 2021-2029.
This report focuses on Filgrastim Injection volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Filgrastim Injection market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Filgrastim Injection Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2029. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Dosage Form & Strength Type
300mcg/mL (vial)
480mcg/1.6 mL (vial)
300mcg/0.5mL (Prefilled Syringe)
480mcg/0.8mL (Prefilled Syringe)
Segment by Application
Adult Use
Pediatric Use
Geriatric Use
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Accord Healthcare
Teva Pharmaceuticals
Pfizer
Amgen Inc
Novartis AG
1 Filgrastim Injection Market Overview
1.1 Product Overview and Scope of Filgrastim Injection
1.2 Filgrastim Injection Segment by Dosage Form & Strength Type
1.2.1 Global Filgrastim Injection Sales Growth Rate Comparison by Dosage Form & Strength Type (2021-2029)
1.2.2 300mcg/mL (vial)
1.2.3 480mcg/1.6 mL (vial)
1.2.4 300mcg/0.5mL (Prefilled Syringe)
1.2.5 480mcg/0.8mL (Prefilled Syringe)
1.3 Filgrastim Injection Segment by Application
1.3.1 Global Filgrastim Injection Sales Comparison by Application: (2021-2029)
1.3.2 Adult Use
1.3.3 Pediatric Use
1.3.4 Geriatric Use
1.4 Global Filgrastim Injection Market Size Estimates and Forecasts
1.4.1 Global Filgrastim Injection Revenue 2016-2029
1.4.2 Global Filgrastim Injection Sales 2016-2029
1.4.3 Filgrastim Injection Market Size by Region: 2016 Versus 2021 Versus 2029
2 Filgrastim Injection Market Competition by Manufacturers
2.1 Global Filgrastim Injection Sales Market Share by Manufacturers (2016-2021)
2.2 Global Filgrastim Injection Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Filgrastim Injection Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Filgrastim Injection Manufacturing Sites, Area Served, Product Type
2.5 Filgrastim Injection Market Competitive Situation and Trends
2.5.1 Filgrastim Injection Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Filgrastim Injection Players Market Share by Revenue
2.5.3 Global Filgrastim Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Filgrastim Injection Retrospective Market Scenario by Region
3.1 Global Filgrastim Injection Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Filgrastim Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Filgrastim Injection Market Facts & Figures by Country
3.3.1 North America Filgrastim Injection Sales by Country
3.3.2 North America Filgrastim Injection Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Filgrastim Injection Market Facts & Figures by Country
3.4.1 Europe Filgrastim Injection Sales by Country
3.4.2 Europe Filgrastim Injection Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Filgrastim Injection Market Facts & Figures by Region
3.5.1 Asia Pacific Filgrastim Injection Sales by Region
3.5.2 Asia Pacific Filgrastim Injection Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Filgrastim Injection Market Facts & Figures by Country
3.6.1 Latin America Filgrastim Injection Sales by Country
3.6.2 Latin America Filgrastim Injection Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Filgrastim Injection Market Facts & Figures by Country
3.7.1 Middle East and Africa Filgrastim Injection Sales by Country
3.7.2 Middle East and Africa Filgrastim Injection Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Filgrastim Injection Historic Market Analysis by Dosage Form & Strength Type
4.1 Global Filgrastim Injection Sales Market Share by Dosage Form & Strength Type (2016-2021)
4.2 Global Filgrastim Injection Revenue Market Share by Dosage Form & Strength Type (2016-2021)
4.3 Global Filgrastim Injection Price by Dosage Form & Strength Type (2016-2021)
5 Global Filgrastim Injection Historic Market Analysis by Application
5.1 Global Filgrastim Injection Sales Market Share by Application (2016-2021)
5.2 Global Filgrastim Injection Revenue Market Share by Application (2016-2021)
5.3 Global Filgrastim Injection Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Accord Healthcare
6.1.1 Accord Healthcare Corporation Information
6.1.2 Accord Healthcare Description and Business Overview
6.1.3 Accord Healthcare Filgrastim Injection Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Accord Healthcare Filgrastim Injection Product Portfolio
6.1.5 Accord Healthcare Recent Developments/Updates
6.2 Teva Pharmaceuticals
6.2.1 Teva Pharmaceuticals Corporation Information
6.2.2 Teva Pharmaceuticals Description and Business Overview
6.2.3 Teva Pharmaceuticals Filgrastim Injection Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Teva Pharmaceuticals Filgrastim Injection Product Portfolio
6.2.5 Teva Pharmaceuticals Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Filgrastim Injection Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Pfizer Filgrastim Injection Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Amgen Inc
6.4.1 Amgen Inc Corporation Information
6.4.2 Amgen Inc Description and Business Overview
6.4.3 Amgen Inc Filgrastim Injection Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Amgen Inc Filgrastim Injection Product Portfolio
6.4.5 Amgen Inc Recent Developments/Updates
6.5 Novartis AG
6.5.1 Novartis AG Corporation Information
6.5.2 Novartis AG Description and Business Overview
6.5.3 Novartis AG Filgrastim Injection Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Novartis AG Filgrastim Injection Product Portfolio
6.5.5 Novartis AG Recent Developments/Updates
7 Filgrastim Injection Manufacturing Cost Analysis
7.1 Filgrastim Injection Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Filgrastim Injection
7.4 Filgrastim Injection Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Filgrastim Injection Distributors List
8.3 Filgrastim Injection Customers
9 Filgrastim Injection Market Dynamics
9.1 Filgrastim Injection Industry Trends
9.2 Filgrastim Injection Growth Drivers
9.3 Filgrastim Injection Market Challenges
9.4 Filgrastim Injection Market Restraints
10 Global Market Forecast
10.1 Filgrastim Injection Market Estimates and Projections by Dosage Form & Strength Type
10.1.1 Global Forecasted Sales of Filgrastim Injection by Dosage Form & Strength Type (2022-2029)
10.1.2 Global Forecasted Revenue of Filgrastim Injection by Dosage Form & Strength Type (2022-2029)
10.2 Filgrastim Injection Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Filgrastim Injection by Application (2022-2029)
10.2.2 Global Forecasted Revenue of Filgrastim Injection by Application (2022-2029)
10.3 Filgrastim Injection Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Filgrastim Injection by Region (2022-2029)
10.3.2 Global Forecasted Revenue of Filgrastim Injection by Region (2022-2029)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Filgrastim Injection Sales (KL) Growth Rate Comparison by Dosage Form & Strength Type (2021-2029)
Table 2. Global Filgrastim Injection Sales (KL) Comparison by Application (2021-2029)
Table 3. Global Filgrastim Injection Market Size by Region (US$ Million) (2016 VS 2021 VS 2029)
Table 4. Key Manufacturers Filgrastim Injection Covered in This Study
Table 5. Global Filgrastim Injection Sales (KL) of Key Manufacturers (2016-2021)
Table 6. Global Filgrastim Injection Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Filgrastim Injection Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Filgrastim Injection Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Filgrastim Injection Average Price (US$/L) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Filgrastim Injection Manufacturing Sites and Area Served
Table 11. Manufacturers Filgrastim Injection Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Filgrastim Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Filgrastim Injection as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Filgrastim Injection Sales by Region (2016-2021) & (KL)
Table 16. Global Filgrastim Injection Sales Market Share by Region (2016-2021)
Table 17. Global Filgrastim Injection Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Filgrastim Injection Sales by Country (2016-2021) & (KL)
Table 19. North America Filgrastim Injection Sales Market Share by Country (2016-2021)
Table 20. North America Filgrastim Injection Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Filgrastim Injection Revenue Market Share by Country (2016-2021)
Table 22. Europe Filgrastim Injection Sales by Country (2016-2021) & (KL)
Table 23. Europe Filgrastim Injection Sales Market Share by Country (2016-2021)
Table 24. Europe Filgrastim Injection Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Filgrastim Injection Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Filgrastim Injection Sales by Region (2016-2021) & (KL)
Table 27. Asia Pacific Filgrastim Injection Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Filgrastim Injection Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Filgrastim Injection Revenue Market Share by Region (2016-2021)
Table 30. Latin America Filgrastim Injection Sales by Country (2016-2021) & (KL)
Table 31. Latin America Filgrastim Injection Sales Market Share by Country (2016-2021)
Table 32. Latin America Filgrastim Injection Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Filgrastim Injection Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Filgrastim Injection Sales by Country (2016-2021) & (KL)
Table 35. Middle East and Africa Filgrastim Injection Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Filgrastim Injection Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Filgrastim Injection Revenue Market Share by Country (2016-2021)
Table 38. Global Filgrastim Injection Sales (KL) by Dosage Form & Strength Type (2016-2021)
Table 39. Global Filgrastim Injection Sales Market Share by Dosage Form & Strength Type (2016-2021)
Table 40. Global Filgrastim Injection Revenue (Million US$) by Dosage Form & Strength Type (2016-2021)
Table 41. Global Filgrastim Injection Revenue Share by Dosage Form & Strength Type (2016-2021)
Table 42. Global Filgrastim Injection Price (US$/L) by Dosage Form & Strength Type (2016-2021)
Table 43. Global Filgrastim Injection Sales (KL) by Application (2016-2021)
Table 44. Global Filgrastim Injection Sales Market Share by Application (2016-2021)
Table 45. Global Filgrastim Injection Revenue (Million US$) by Application (2016-2021)
Table 46. Global Filgrastim Injection Revenue Share by Application (2016-2021)
Table 47. Global Filgrastim Injection Price (US$/L) by Application (2016-2021)
Table 48. Accord Healthcare Corporation Information
Table 49. Accord Healthcare Description and Business Overview
Table 50. Accord Healthcare Filgrastim Injection Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 51. Accord Healthcare Filgrastim Injection Product
Table 52. Accord Healthcare Recent Developments/Updates
Table 53. Teva Pharmaceuticals Corporation Information
Table 54. Teva Pharmaceuticals Description and Business Overview
Table 55. Teva Pharmaceuticals Filgrastim Injection Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 56. Teva Pharmaceuticals Filgrastim Injection Product
Table 57. Teva Pharmaceuticals Recent Developments/Updates
Table 58. Pfizer Corporation Information
Table 59. Pfizer Description and Business Overview
Table 60. Pfizer Filgrastim Injection Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 61. Pfizer Filgrastim Injection Product
Table 62. Pfizer Recent Developments/Updates
Table 63. Amgen Inc Corporation Information
Table 64. Amgen Inc Description and Business Overview
Table 65. Amgen Inc Filgrastim Injection Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 66. Amgen Inc Filgrastim Injection Product
Table 67. Amgen Inc Recent Developments/Updates
Table 68. Novartis AG Corporation Information
Table 69. Novartis AG Description and Business Overview
Table 70. Novartis AG Filgrastim Injection Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 71. Novartis AG Filgrastim Injection Product
Table 72. Novartis AG Recent Developments/Updates
Table 73. Production Base and Market Concentration Rate of Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Filgrastim Injection Distributors List
Table 76. Filgrastim Injection Customers List
Table 77. Filgrastim Injection Market Trends
Table 78. Filgrastim Injection Growth Drivers
Table 79. Filgrastim Injection Market Challenges
Table 80. Filgrastim Injection Market Restraints
Table 81. Global Filgrastim Injection Sales Forecast by Dosage Form & Strength Type (2022-2029) & (KL)
Table 82. Global Filgrastim Injection Sales Market Share Forecast by Dosage Form & Strength Type (2022-2029)
Table 83. Global Filgrastim Injection Revenue Forecast by Dosage Form & Strength Type (2022-2029) & (US$ Million)
Table 84. Global Filgrastim Injection Revenue Market Share Forecast by Dosage Form & Strength Type (2022-2029)
Table 85. Global Filgrastim Injection Sales Forecast by Application (2022-2029) & (KL)
Table 86. Global Filgrastim Injection Sales Market Share Forecast by Application (2022-2029)
Table 87. Global Filgrastim Injection Revenue Forecast by Application (2022-2029) & (US$ Million)
Table 88. Global Filgrastim Injection Revenue Market Share Forecast by Application (2022-2029)
Table 89. Global Filgrastim Injection Sales Forecast by Region (2022-2029) & (KL)
Table 90. Global Filgrastim Injection Sales Market Share Forecast by Region (2022-2029)
Table 91. Global Filgrastim Injection Revenue Forecast by Region (2022-2029) & (US$ Million)
Table 92. Global Filgrastim Injection Revenue Market Share Forecast by Region (2022-2029)
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Filgrastim Injection
Figure 2. Global Filgrastim Injection Market Share by Dosage Form & Strength Type in 2020 & 2029
Figure 3. 300mcg/mL (vial) Product Picture
Figure 4. 480mcg/1.6 mL (vial) Product Picture
Figure 5. 300mcg/0.5mL (Prefilled Syringe) Product Picture
Figure 6. 480mcg/0.8mL (Prefilled Syringe) Product Picture
Figure 7. Global Filgrastim Injection Market Share by Application in 2020 & 2029
Figure 8. Adult Use
Figure 9. Pediatric Use
Figure 10. Geriatric Use
Figure 11. Global Filgrastim Injection Revenue, (US$ Million), 2016 VS 2021 VS 2029
Figure 12. Global Filgrastim Injection Market Size 2016-2029 (US$ Million)
Figure 13. Global Filgrastim Injection Sales 2016-2029 (KL)
Figure 14. Global Filgrastim Injection Market Size Market Share by Region: 2016 VS 20210 VS 2029
Figure 15. Filgrastim Injection Sales Share by Manufacturers in 2020
Figure 16. Global Filgrastim Injection Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Filgrastim Injection Players: Market Share by Revenue in 2020
Figure 18. Filgrastim Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Filgrastim Injection Sales Market Share by Region (2016-2021)
Figure 20. Global Filgrastim Injection Sales Market Share by Region in 2020
Figure 21. Global Filgrastim Injection Revenue Market Share by Region (2016-2021)
Figure 22. Global Filgrastim Injection Revenue Market Share by Region in 2020
Figure 23. United States Filgrastim Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Filgrastim Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Filgrastim Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Filgrastim Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Filgrastim Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Filgrastim Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Filgrastim Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Filgrastim Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Filgrastim Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Filgrastim Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Filgrastim Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Filgrastim Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. China Taiwan Filgrastim Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Filgrastim Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Filgrastim Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Filgrastim Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Filgrastim Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Filgrastim Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Filgrastim Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Filgrastim Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Filgrastim Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Filgrastim Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Filgrastim Injection by Dosage Form & Strength Type (2016-2021)
Figure 46. Sales Market Share of Filgrastim Injection by Application (2016-2021)
Figure 47. Sales Market Share of Filgrastim Injection by Application in 2020
Figure 48. Revenue Share of Filgrastim Injection by Application (2016-2021)
Figure 49. Revenue Share of Filgrastim Injection by Application in 2020
Figure 50. Manufacturing Cost Structure of Filgrastim Injection
Figure 51. Manufacturing Process Analysis of Filgrastim Injection
Figure 52. Filgrastim Injection Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
Consulting report: +86-15323335301 020-31521856
